|
|
|
0 members (),
5,008
guests, and
31
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
|
1
|
2
|
3
|
4
|
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
|
26
|
27
|
28
|
29
|
30
|
31
|
|
|
There are no members with birthdays on this day. |
Volcano earthquake report for Friday, 10 Jul 2026
• Moderate mag. 4.2 earthquake - 133 km northwest of Ternate, Kota Ternate, N...
• World Earthquake Report for Friday, 10 July 2026
• Moderate mag. 4.6 earthquake - 17 km southwest of Comalapa, Estado de Chiap...
• Moderate mag. 4.1 earthquake - Olyutorskiy Rayon, 47 km northwest of Tilich...
• Moderate mag. 4.0 earthquake - Hawke's Bay, New Zealand, on Saturday, Jul 1...
|
#224352
Fri 23 May 2014 06:54:PM
|
Joined: Feb 2001
Posts: 678,976
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 678,976 |
A new chemotherapy drug being investigated for its potency against two types of cancer was found by scientists to be effective in about one-third of the 58 patients who participated in a phase I study. The drug, alisertib or MLN8237, inhibits the enzyme aurora A kinase, which is known to be very active during cell division. The present study looks at the safety, tolerability, and preliminary success of alisertib in treating non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).  Source: New drug for non-Hodgkin lymphoma, chronic lymphocytic leukemia passes early test
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Entire Thread
|
New drug for non-Hodgkin lymphoma, chronic lymphocytic leukemia passes early test
|
Webmaster
|
Fri 23 May 2014 06:54:PM
|
|
Forums60
Topics789,809
Posts824,587
Members2,960
| |
Most Online102,106
Jul 10th, 2026
|
|
|
|
|
Copyright 1996 - 2026 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under this agreement to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and AUS-CITY mailing lists are distributed with permission from DoD/USSTRATCOM.
|
|
